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A 36-year-old woman, gravida 4, para 0, was referred
for amniocentesis at 18 gestational weeks because of
advanced maternal age and an autosomal reciprocal
translocation in her second spouse. This was the woman’s
fourth pregnancy, and she had experienced two preterm
deliveries with neonatal death during her previous mar-
riage and one spontaneous abortion following a rela-
tionship with her current spouse. Nine years before,
the ex-wife of the woman’s current spouce gave birth
to a growth-restricted malformed baby at term with a
karyotype of 46,XX,der(22)t(16;22)(q12.1;q13.3) and
an unbalanced reciprocal translocation between 16q and
22q [1]. The baby’s chromosomal aberration led to the
diagnosis of a 46,XY,t(16;22)(q12.1;q13.3) karyotype
in the man. Four years later, the man’s ex-wife delivered
a malformed baby again with a karyotype of 46,XX,
der(22)t(16;22)(q12.1;q13.3) [2]. During this preg-
nancy, amniocentesis at 18 gestational weeks revealed
a karyotype of 46,XX,der(22)t(16;22)(q12.1;q13.3)
(Figure 1). Level II ultrasound revealed a singleton with
fetal biometry consistent with the gestational age, doli-
chocephaly, decreased fetal movements and a thickened
nuchal fold. The pregnancy was subsequently terminated.
At 22 gestational weeks, a 342 g malformed female
fetus was delivered with a high forehead, bitemporal
narrowing, frontal bossing, dolichocephaly, a promi-
nent nose, hypertelorism, large low-set ears, microg-
nathia, a short neck with a thickened nuchal fold and
clinodactyly (Figure 2). Array comparative genomic
hybridization (aCGH) using genomic DNA extracted
from the uncultured umbilical cord confirmed a distal
16q duplication and a terminal 22q deletion (Figure 3).
We previously reported the prenatal diagnosis of an
inherited unbalanced reciprocal translocation by aCGH
using uncultured amniocytes [3]. Our case demonstrates
that aCGH can be applied for rapid confirmation of
prenatally diagnosed aneuploidy using uncultured post-
natal tissues. The present case manifested some of the
characteristic features associated with 22q13.3 deletion
syndrome and partial trisomy 16q. The 22q13.3 dele-
tion syndrome or Phelan-McDermid syndrome (OMIM
606232) is characterized by long eye lashes, large or
unusual ears, relatively large hands, dysplastic toenails,
a full brow, dolichocephaly, ptosis, full cheeks, a bulbous
nose, a pointed chin, autistic behavior, neonatal hypo-
tonia, global developmental delay, normal or acceler-
ated growth and absent to severely delayed speech [4].
The reported abnormal findings of trisomy 16q on pre-
natal ultrasound include hydrocephalus, intrauterine
growth restriction, micrognathia, congenital heart de-
fects, clinodactyly and abnormal external genitalia [5,6].
The present case had haploinsufficiency of the SHANK3
gene (49,459,936–49,518,507 bp) (NCBI Build 36).
Haploinsufficiency of the SHANK3 gene is a major cause
of the neurological symptoms of the 22q13 deletion syn-
drome [7,8]. The abnormal gene dosage of SHANK3 is
associated with autism spectrum disorders and language
and speech disorders [8].
In the present case, the reason for prenatal chromo-
some analysis was the paternal carrier status, which was
primarily ascertained through a previous term aneuploid
child. Inherited unbalanced structural chromosomal
abnormalities detected at prenatal chromosome analysis
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are most commonly ascertained through a previous
child with an unbalanced karyotype [9]. In a study of
56 inherited unbalanced structural chromosomal abnor-
malities detected at prenatal chromosome analysis,
Franssen et al [9] found that the modes of ascertainment
were a previous child with an unbalanced karyotype
(48%, 27/56), ultrasound abnormalities (20%, 11/56),
advanced maternal age (9%, 5/56), abnormal serum
screening (4%, 2/56), abnormal nuchal translucency
(4%, 2/56), intracytoplasmic sperm injection (4%, 2/56),
Figure 1. 46,XX,der(22)t(16;22)(q12.1;q13.3) karyotype in the fetus. The arrows indicate the breakpoints.
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Figure 2. (A) Anterior view and (B) lateral view of a fetus with dolichocephaly, bitemporal narrowing, a short neck, frontal
bossing, a prominent nose, hypertelorism, large low-set ears and micrognathia, and (C) clinodactyly.
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Figure 3. Whole genome view of array comparative genomic hybridization shows a distal 16q duplication (arrows at chromo-
some 16) and a terminal 22q deletion (arrows at chromosome 22).
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and recurrent miscarriage (2%, 1/56), among others.
Structural chromosomal rearrangements in couples are
usually identified through recurrent miscarriages, previ-
ous aneuploid live birth or stillbirth, and prenatal diag-
nosis of chromosomal aberrations. Chen et al [10,11]
found that 17 of 22 (77.3%) families with prenatal diag-
nosis of an inherited acrocentric rearrangement by
amniocentesis were aware of their carrier status only
after the diagnosis of a fetus with a translocation.
Structural chromosomal rearrangements in couples
are estimated to be 2.2% after one miscarriage, 4.8%
after two miscarriages and 5.2% after three miscarriages
compared with 0.7% in the general population [12–14].
In a study of reproductive outcome after chromosome
analysis in couples with two or more miscarriages,
Franssen et al [15] concluded that the risk (0.4% at pre-
natal diagnosis and 0.4% at birth) of viable offspring
with chromosomal abnormalities was low, and that
the chance of having a healthy child (83%) was as high
as that of non-carrier couples (84%) despite a higher
risk of a subsequent miscarriage. Nonetheless, carrier
couples ascertained through a previous aneuploid child
are at a higher risk of having unbalanced viable offspring
than those ascertained through miscarriages [15–18].
Boué and Gallano [16] reported a 20.8% risk of unbal-
anced fetuses at prenatal diagnosis when the translo-
cation was ascertained through an aneuploid infant,
compared with a risk of 4.9% when the ascertainment
was through other means. Daniel et al [17] reported a
20–25% risk of unbalanced pregnancy in carriers of 2:2
segregating reciprocal translocations ascertained by
previous term unbalanced offspring irrespective of car-
rier parents. Barišic´ et al [18] reported a 31.6% risk of
an unbalanced fetal karyotype at prenatal diagnosis
when the translocation was determined through an
aneuploid infant, compared with a risk of 11.8% when
the ascertainment was through spontaneous abortions.
Therefore, for carrier couples whose carrier status is
determined through a previous aneuploid child, pre-
implantation genetic diagnosis by fluorescence in situ
hybridization [19] or by whole genome amplification
[20,21] may be an alternative to prenatal diagnosis in
cases where there are multiple failed attempts to
achieve a successful pregnancy.
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